srl_clinic_logo

About us

Dr. Sweta Kothari

ABOUT US

Dr. Sweta Lunkad

Dr. Sweta Lunkad, a distinguished Hematologist, stands as a beacon of hope for those seeking the best in medical expertise. With a specialization in Clinical Hematology and a wealth of experience, Dr. Lunkad is not just a doctor but a trusted partner on your journey to better health.

About Dr. Sweta Lunkad:

Dr. Sweta Lunkad, a seasoned Hematologist, brings a unique blend of expertise and empathy to the world of healthcare. Armed with a DM in Clinical Hematology, she is committed to delivering the highest standard of care to her patients. Dr. Lunkad’s dedication to advancing her knowledge ensures that she remains at the forefront of Hematology, offering the best possible treatments and solutions.

Best Doctor in Hematology:

Dr. Sweta Lunkad is not merely a Hematologist; she is celebrated as one of the best doctors in the field of Hematology. Her reputation is founded on a wealth of experience, academic brilliance, and a proven track record of positive patient outcomes.

Clinical Hematology Expertise:

With a specialized focus on Clinical Hematology, Dr. Lunkad possesses a profound understanding of the complexities surrounding blood disorders. Her expertise extends across a diverse range of hematological conditions, allowing her to provide nuanced and targeted care to her patients.

Diagnostic Prowess:

At the core of Dr. Lunkad’s expertise lies her diagnostic prowess. Proficient in Bone Marrow Aspiration and Biopsy Consultation, she navigates these critical procedures with precision, ensuring accurate diagnoses that serve as the foundation for effective treatment strategies.

Compassionate Chemotherapy Administration:

In the realm of blood cancers, Dr. Lunkad’s proficiency in chemotherapy administration is noteworthy. Her clinical acumen is complemented by a compassionate approach, creating an environment where patients feel supported and cared for during their treatment journey.

Championing Immunotherapy:

Dr. Lunkad is at the forefront of medical advancements, particularly in the realm of immunotherapy. As a champion of this cutting-edge treatment, she explores innovative possibilities that harness the body’s immune system to combat blood cancers, offering new hope to her patients.

Holistic Patient-Centric Approach:

Beyond her medical expertise, Dr. Lunkad adopts a holistic and patient-centric approach to healthcare. She recognizes the importance of addressing not only the physical aspects but also the emotional and psychological well-being of her patients, creating a comprehensive healthcare experience.

Positive Patient Outcomes:

Dr. Lunkad’s dedication to her patients is evident in the positive outcomes she consistently achieves. Her commitment to staying updated on the latest developments in Hematology ensures that patients benefit from the most advanced and effective treatments available.

Accessible and Supportive:

Dr. Lunkad transcends the traditional doctor-patient relationship by creating an accessible and supportive environment. Her approachable demeanor and willingness to address patient concerns contribute to a positive and reassuring healthcare experience.

In choosing Dr. Sweta Lunkad, you are not just selecting a doctor; you are entrusting your health to a compassionate expert in Clinical Hematology. With a reputation as one of the best doctors in her field, Dr. Lunkad’s unwavering commitment to excellence and patient care shines through in every aspect of her practice. Welcome to a healthcare experience where expertise meets compassion under the guidance of Dr. Sweta Lunkad.

Awards & Presentations

1. “Epidemiology of co-existence of Diabetes and hypertension in railway population” as a Post graduate Dissertation. Accepted in 2010
2. Reversible Posterior Leukoencephalopathy Syndrome in A Case of Adult-Onset Still’s Disease with Concurrent Thrombotic Thrombocytopenic Purpura: Response to High Dose Immunoglobulin Infusions; JAPI • November 2012 • VOL. 60
3. Haploidentical Hematopoietic Stem Cell Transplant for Thalassemia Major Using pre transplant immunosuppression and Post Transplant Cyclophosphamide; EBMT16-PH-2014
4. Awarded with “Doctor of Month” award at Dr.B.L.Kapur Hospital Delhi in 2015.
5. Presented a poster titled “Haploidentical hematopoietic stem cell transplant for thalassemia major using fludarabine – busulphan- thymoglobulin and post-transplant cyclophosphamide: early experience”; APBMT2016-ABS-190 at Okinaka, Japan.
6. Presented a poster titled “Bone marrow transplant for recessive dystrophic epidermolysis bullosa: a case report; APBMT2016-ABS-216” at Okinaka, Japan.
7. Peripheral Blood Stem Cell Collection on Day 4 Is Feasible and Safe in a Majority of Allogeneic Stem Cell Transplant Donors; 2016 BMT Tandem Meetings
8. Hematopoietic Stem Cell transplant in Elderly Patients: Experience from a tertiary care center in Northern India; Indian J Hematol Blood Transfuse DOI 10.1007/s12288-015-0624-0
9. Day 4 Peripheral Blood Stem Cell Collection in Myeloma Patients is Feasible and Cost-effective in a Majority of Patients, 15th International Myeloma Workshop Rome, September 23-26, 2015.
10. An Unusual Cause of Anemia and Encephalopathy; Mediterr J Hematol Infect Dis www.mjhid.org 2015; 7
11. Renal Involvement in Multiple Myeloma, ISHBT-EHA; Eposter
12. To determine if colonization of gut with carbapenem resistant Enterobacteriaceae in surveillance cultures affect the outcome of high-risk febrile neutropenic patients”; EHA-1397; EHA 2018
13. Presented a poster titled “Gut colonization with carbapenem resistant Enterobacteriaceae leads to more chemotherapy interruptions and higher mortality in patient with acute leukemia receiving remission induction chemotherapy”; ASH-4002; ASH 2018 at San Diago, USA which was given a travel grant by ICMR (Indian council of medical research) New Delhi.
14. “To determine if colonization of gut with carbapenems resistant Enterobacteriaceae in surveillance culture affects the outcome of high-risk febrile neutropenic patients” as a DM research project, Submitted to AIIMS in Jan 2019.